1. Home
  2. BEDU vs SPRO Comparison

BEDU vs SPRO Comparison

Compare BEDU & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEDU
  • SPRO
  • Stock Information
  • Founded
  • BEDU 1994
  • SPRO 2013
  • Country
  • BEDU United Kingdom
  • SPRO United States
  • Employees
  • BEDU N/A
  • SPRO N/A
  • Industry
  • BEDU Other Consumer Services
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BEDU Real Estate
  • SPRO Health Care
  • Exchange
  • BEDU Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • BEDU 58.7M
  • SPRO 63.0M
  • IPO Year
  • BEDU 2017
  • SPRO 2017
  • Fundamental
  • Price
  • BEDU $2.00
  • SPRO $1.05
  • Analyst Decision
  • BEDU
  • SPRO Buy
  • Analyst Count
  • BEDU 0
  • SPRO 3
  • Target Price
  • BEDU N/A
  • SPRO $5.00
  • AVG Volume (30 Days)
  • BEDU 9.3K
  • SPRO 205.6K
  • Earning Date
  • BEDU 02-03-2025
  • SPRO 11-14-2024
  • Dividend Yield
  • BEDU N/A
  • SPRO N/A
  • EPS Growth
  • BEDU N/A
  • SPRO N/A
  • EPS
  • BEDU N/A
  • SPRO 0.06
  • Revenue
  • BEDU $247,588,726.00
  • SPRO $106,455,000.00
  • Revenue This Year
  • BEDU N/A
  • SPRO N/A
  • Revenue Next Year
  • BEDU N/A
  • SPRO N/A
  • P/E Ratio
  • BEDU N/A
  • SPRO $16.37
  • Revenue Growth
  • BEDU N/A
  • SPRO 37.01
  • 52 Week Low
  • BEDU $1.23
  • SPRO $1.01
  • 52 Week High
  • BEDU $3.23
  • SPRO $1.89
  • Technical
  • Relative Strength Index (RSI)
  • BEDU 52.31
  • SPRO 31.12
  • Support Level
  • BEDU $1.75
  • SPRO $1.12
  • Resistance Level
  • BEDU $2.16
  • SPRO $1.20
  • Average True Range (ATR)
  • BEDU 0.12
  • SPRO 0.04
  • MACD
  • BEDU 0.02
  • SPRO -0.01
  • Stochastic Oscillator
  • BEDU 43.90
  • SPRO 13.67

About BEDU Bright Scholar Education Holdings Limited each representing four

Bright Scholar Education Holdings Ltd operates as an education service provider. The company offers overseas schools, complementary education services, and domestic kindergartens and K12 operation services. The group's overseas K12 education has several K12 schools, art colleges, language training institutions, and summer schools around the world. The complimentary education services segment of the company predominantly includes camp programs, after-school programs, through a network of learning centers in China, as well as international education consulting services. Geographically, the company operates in China which is the key revenue generating market, Canada, United States, and United Kingdom.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: